Revision: Feb. 28, 2019, 3:25 p.m.
HB 627 - AS AMENDED BY THE HOUSE
27Feb2019... 0396h
2019 SESSION
19-0712
10/01
HOUSE BILL 627
AN ACT relative to rulemaking by the board of pharmacy on compounding.
SPONSORS: Rep. Long, Hills. 10
COMMITTEE: Executive Departments and Administration
-----------------------------------------------------------------
AMENDED ANALYSIS
This bill removes compliance with the United States Pharmacopeia for compounding of drugs and provides that compounding shall be subject to rules adopted by the board of pharmacy.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
27Feb2019... 0396h 19-0712
10/01
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Nineteen
AN ACT relative to rulemaking by the board of pharmacy on compounding.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 Pharmacy; Compounding; Rulemaking. Amend RSA 318:14-a, I to read as follows:
I. Products that are not commercially available may be compounded for hospital or office use but shall not be resold or dispensed. Nonprescription items may be compounded upon order by a practitioner for sale as long as the labeling complies with RSA 318:47-a and the product is not a copy of, or similar to, prescription or nonprescription products. All compounding shall be done in compliance with [the United States Pharmacopeia as defined] rules adopted by the board of pharmacy [rules].
2 Effective Date. This act shall take effect 60 days after its passage.